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Tissue Engineering and Regenerative Medicine
WNT-C59, a Small-MoleculeWNT Inhibitor, Efficiently
Induces Anterior Cortex That Includes Cortical Motor
Neurons From Human Pluripotent Stem Cells
MAKOTO MOTONO,a YOSHIHIKO IOROI,a,b TAKENORI OGURA,a,b JUN TAKAHASHIa,b
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ABSTRACT
The recapitulation of human neural development in a controlled, definedmanner from pluripotent stem
cells (PSCs) has considerable potential for studies of human neural development, circuit formation and
function, and the construction of in vitromodels of neurological diseases. The inhibition ofWnt signaling,
oftenby the recombinantproteinDKK1, is important for the inductionof corticalneurons.Here,we report
anoveldifferentiationmethodusinga small-moleculeWNT inhibitor,WNT-C59 (C59), toefficiently induce
humananterior cortex.Wecompared twotypesof smallmolecules, C59andXAV939 (XAV), as substitutes
for DKK1 to induce cortical neurons fromPSCs in serum-free embryoid body-like aggregate culture. DKK1
andXAV inhibited only the canonical pathwayofWnt signaling,whereas C59 inhibited both the canonical
and noncanonical pathways. C59 efficiently induced CTIP2+/COUP-TF12 cells, which are characteristic of
the cells found in the anterior cortex. In addition, when grafted into the cortex of adult mice, the C59-
induced cells showedabundant axonal fiber extension toward the spinal cord. These results raise thepos-
sibility of C59 contributing to cell replacement therapy formotor neuron diseases or insults. STEMCELLS
TRANSLATIONAL MEDICINE 2016;5:552–560
SIGNIFICANCE
For a cell therapy against damaged corticospinal tract caused by neurodegenerative diseases or in-
sults, cortical motor neurons are needed. Currently, their induction from pluripotent stem cells is
considered very promising; however, an efficient protocol to induce motor neurons is not available.
For efficient induction of anterior cortex, where motor neurons are located, various WNT inhibitors
were investigated. It was found that one of them could induce anterior cortical cells efficiently. In
addition, when grafted into the cortex of adultmice, the induced cells showedmore abundant axonal
fiber extension toward spinal cord. These results raise the possibility that this inhibitor contributes to
a cell-replacement therapy for motor neuron diseases or insults.
INTRODUCTION
Movementdependsonsignalingpathwaysoriginat-
ing from the motor cortex. The mammalian motor
cortex has a six-layered structure. Layer V includes
cortical motor neurons (CMNs) that have a pyrami-
dal shape and extend axons to innervatemotor neu-
rons in the spinal cord [1]. Thedegenerationof CMNs
causesmotor neurondiseases including amyotrophic
lateral sclerosis (ALS) and hereditary spastic paraple-
gia [2]. A loss or deterioration ofmotor functions can
also occur upon stroke or brain injury that causes the
death of CMNs.
Cell replacement therapy is gaining consider-
able attention to treat motor dysfunctions. Fetal
frontal cortex cells transplanted into the frontal
region of neonatal [3] or adult [4] mice were
found to extend axons to the spinal cord. These
findings suggest that the transplantation of fetal
frontal cortex,which includesCMNprogenitor cells,
is able to reconstitute the corticospinal pathway.
However, human fetal brains are not a feasible
sourceofdonorcells.Alternativedonorcells include
embryonic stem cells (ESCs) and induced pluripo-
tent stem cells (iPSCs). These PSCs can be unlimit-
edly expanded and give rise to a wide variety of
differentiated cells, making them a promising cell
source for treating intractable neurological disor-
ders, including Parkinson’s disease [5–7] and ALS
[8]. In fact, recent studies have shown that mouse
[9] or human [10] ESC-derived neurons extend long
axons from themotor cortex to the pyramidal tract
in neonate mice. However, the efficiency to induce
CMNs from ESCs or iPSCs is very low.
Inordertoinducecorticalneuronsfrommouseor
human ESCs/iPSCs, serum-free embryoid body-like
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aggregates (SFEB) [11–13] or monolayer [9, 10, 14–17] protocols
are used. CMNs are located in the frontal/motor area of the an-
terior cortex, and the inhibition of Wnt signaling is important to
induce this area. WNTs contribute to the proper patterning of
neural structures along the anterior-posterior axis [18]. In these
methods, a recombinant protein, DKK1, is used as theWNT inhib-
itor. However, DKK1 is produced in animal cells and Escherichia
coli, raising the possibility of infection or immune rejection due
to cross-species contamination when the induced cells are trans-
planted to humans. Therefore, an alternativeWNT inhibitor to in-
duce CMNs is required for clinical application.
In the present study, we investigated the effects of two small
compounds as substituteWNT inhibitors in an induction protocol
for cortical neurons from human iPSCs: WNT-C59 (C59) and
XAV939 (XAV) (supplemental online Fig. 1). C59 inhibits the
activity of porcupine (PORCN), which is a membrane-bound
O-acyltransferase required for palmitoylation, secretion, and
the biological activity of WNTs. The inhibition of PORCN by
C59 prevents both canonical and noncanonical Wnt-mediated
signaling [19]. XAV inhibits tankyrase 1 and 2, thus stabilizing
axin and stimulating b-catenin degradation [20], whereas
DKK1 inhibits WNT binding to its receptor, LRP5/6 [21]. In other
words, XAV and DKK1 inhibit only canonical Wnt signaling. We
induced cortical neurons from human iPSCs in the presence of
DKK1, XAV, or C59 and found that C59 induced frontal cortical
neurons expressing a marker for layer V (CTIP2+/COUP-TF12)
most efficiently. This result suggests that C59 can be used to in-
duce CMNs or their progenitors from human iPSCs.
MATERIALS AND METHODS
Maintenance and Differentiation Culture of
Human ESCs/iPSCs
Human iPSCs (836B1) were maintained on SNL feeder cells inac-
tivated by mitomycin C (Wako Pure Chemical Industries, Ltd.,
Osaka, Japan, http://www.wako-chem.co.jp) in Dulbecco’s mod-
ified Eagle’s medium (DMEM)/Ham’s F-12 medium (F12) (Wako)
supplemented with 20% (vol/vol) Knockout Serum Replacement
(KSR; Invitrogen, Tokyo, Japan, http://www.thermofisher.com),
0.1 mM nonessential amino acids (NEAA; Invitrogen), 2 mM
L-glutamine (Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.
com),0.1mM2-mercaptoethanol (Wako), and5ng/mlbasic fibroblast
growth factor (bFGF; Invitrogen). For the induction of cortical
neurons using a serum-free floating culture of embryoid body-
like aggregates with quick reaggregation (SFEBq), feeder cells
were removed with CTK (0.25% [wt/vol] trypsin [Invitrogen] and
0.1% [wt/vol] collagenase IV [Gibco, Tokyo, Japan, http://www.
thermofisher.com] in PBS [Wako] containing 20% KSR [Invitrogen]
and 1 mM CaCl2 [Wako]), and PSCs were dissociated into single
cells by using Accumax (Innovative Cell Technologies, San Diego,
CA, http://www.accutase.com). The cells were counted, and
9,000 cells perwell were aggregated in a low cell binding, Lipidure
coated 96-well plate (NOF Corp., Tokyo, Japan, https://www.nof.
co.jp). The differentiationmedium contained DMEM/F12 supple-
mentedwith 15% (vol/vol) KSR, 0.1mMNEAA, 2mM L-glutamine
(Invitrogen), and 0.1 mM 2-mercaptoethanol (Wako). From day
0 to 3, 50 mM Y-27632 (Wako) was added to the differentiation
medium to increase cell viability. From day 0 to day 6, 10 ng/ml
bFGF (Invitrogen) was added to the medium to increase cell via-
bility and the induction of ectodermal fate [22]. To induce
forebrain fate, the medium was supplemented with WNT inhibitor
(500 ng/ml human recombinant DKK1 [R&D Systems Inc., Minneap-
olis,MN, https://www.rndsystems.com], 0.5mMXAV939 [Stemgent,
Lexington, MA, https://www.stemgent.com], or 10 nM WNT-C59
[Cellagen Technology, San Diego, CA, http://www.cellagentech.
com]) along with 10mMSB431542 (TGF-b/activin/nodal inhibitor;
Sigma-Aldrich) and0.1mMLDN193189 (BMP inhibitor; Stemgent).
On day 18, cell aggregateswere transferred to a 24-well culture plate
coated with 50 mg/ml poly-L-ornithine (Sigma-Aldrich), 5 mg/ml
laminin (BD Biosciences, Heidelberg, Germany, http://www.
bdbiosciences.com), and 5 mg/ml fibronectin (Sigma-Aldrich) in
Neurobasal Medium (Invitrogen) supplemented with 2 mM
L-glutamine (Invitrogen), 2% (vol/vol) B27 (without vitaminA; Invi-
trogen), and 10 units/ml penicillin and streptomycin (Invitrogen).
Medium was changed every 4 or 5 days.
Transplantation
Animals were cared for and handled according to the Guidelines for
Animal Experiments of Kyoto University and the Guide for the Care
and Use of Laboratory Animals of the Institute for Laboratory Animal
Research(Washington,DC,http://dels.nas.edu/ilar).Six- to8-week-old
adult NOD/ShiJic-scid JcI (NOD-SCID) male mice (CLEA Japan Inc.,
Tokyo, Japan,http://www.clea-japan.com)wereanesthetizedwithiso-
flurane (Mylan Inc., Tokyo, Japan, http://www.mylan.co.jp), and cell
transplantation was performed with stereotactic injection of one ag-
gregate (approximately 3 3 105 cells) on differentiation day 46 in
2 ml of PBS (Wako) through a blunt-end 26-gauge Hamilton syringe
needle (Hamilton,Reno,NV,http://www.hamiltoncompany.com) into
therightsideof thecortex (fromthebregma:A,+0.5 to+2.5; L,20.5to
22.5; V,21.0). Six months after transplantation, the animals were
perfused transcardially with 4% paraformaldehyde (PFA; Wako).
The brains and spinal cords were fixed with 4% PFA overnight,
transferred to 30% (wt/vol) sucrose (Nacalai Tesque, Kyoto, Japan,
http://www.nacalai.co.jp) in PBS, and preserved at 4°C. They were
then embedded with O.C.T. Compound (Sakura Finetek, Torrance,
CA, http://www.sakura-americas.com), cut with a cryostat (Leica
Biosystems, Buffalo Grove, IL, http://www.leicabiosystems.com)
at 30-mmthickness andpreserved in antifreeze (30% [vol/vol] glyc-
erol [Nacalai Tesque], 30% [vol/vol] ethylene glycol [Wako], and
40% [vol/vol] 0.1 M PBS) at230°C until use.
Immunostaining
Ondays 18, 32, and46 from thedayof neural induction, individual
aggregates were fixed in 4% PFA (Wako) and washed with and
preserved in PBS at 4°C until use. The aggregateswere embedded
with O.C.T. Compound (Sakura Finetek), cryosectioned at 10 mm
using Cryostat (Leica), and attached to anMAS-coated glass slide
(Matsunami, Osaka, Japan, http://www.matsunami-glass.co.jp).
Cryosections (aggregates and brains) were blocked in 5% (vol/vol)
normal donkey serum (NDS; EMD Millipore, Billerica, MA, http://
www.millipore.com)/0.3% (vol/vol) Triton X-100 (Sigma)/PBS for
1 h at room temperature. Primary antibodies were diluted in 1%
NDS/0.3%TritonX-100/PBSand incubatedovernightat4°C.Thesam-
pleswere thenwashed in0.05%(vol/vol) Tween20 (Nacalai Tesque)/
PBS and incubated with secondary antibodies in 1% NDS/0.3%
Triton X-100/PBS for 2 h at room temperature, followed by washing
in 0.05% Tween 20/PBS and incubation with 49,6-diamidino-2-
phenylindole (Invitrogen) for 10 min at room temperature. Finally,
the sampleswerewashed in0.05%Tween20/PBSandmountedwith
antiphotobleachingmountingmedium(2.4gofMowiol [Calbiochem,
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Billerica, MA, http://www.merckmillipore.com], 6 ml of glycerol
[Wako], 6 ml of distilled water, 12 ml of 200 mM Tris-HCl [Nacalai
Tesque], and 0.66 g of 1.4-diazabicycle[2.2.2]octane [Wako]).
The primary antibodies usedwere as follows: anti-b-catenin
(1:500; Abcam,Cambridge,MA, http://www.abcam.com), anti-PAX6
(1:500; BD Biosciences), anti-MAP2ab (1:2000; Sigma-Aldrich),
anti-b-tubulin (TUJ1; 1:2,000; Covance, Princeton, NJ, http://
www.covance.com), anti-SOX1 (1:1,000; R&D Systems), anti-SOX2
(1:500; R&D Systems), anti-CTIP2 (1:1,000; Abcam), anti-COUP-TF1
(1:1,000; Perseus Proteomics Inc., Tokyo, Japan, http://www.
ppmx.com), anti-SP8 (1:1,000; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, http://www.scbt.com), anti-BRN2 (1:1,000; Santa
Cruz), anti-TBR1 (1:1,000; Millipore), anti-SATB2 (1:200; Abcam),
anti-g-aminobutyric acid (GABA; 1:1,000; Sigma-Aldrich), anti-
tyrosine hydroxylase (1:1,000; Millipore), anti-vesicular gluta-
mate transporter 1 (anti-VGLUT1; 1:1,000; Synaptic Systems,
Goettingen, Germany, http://www.sysy.com), and anti-human
neural cell adhesion molecule (NCAM; 1:1,000; Santa Cruz).
Alexa fluorescent-conjugated antibodies (1:500; Invitrogen)
were used as secondary antibodies. Stained cells and brains
were imagedwith a confocal fluorescencemicroscope (Olympus
Corp., Tokyo, Japan, http://www.olympus.co.jp) and Biorevo
(Keyence Inc., Osaka, Japan, http://www.keyence.co.jp).
Western Blot Analysis
Thedifferentiatedaggregatesonday18wereharvestedandhomog-
enized in lysis buffer (Sigma-Aldrich). The samples were subjected
to sodium dodecyl sulfate polyacrylamide gel electrophoresis
(Bio-Rad, Hercules, CA, http://www.bio-rad.com) and transferred
to polyvinylidene difluoride membranes (GE Healthcare Life Sciences
(GE),Piscataway,NJ,http://www.gelifesciences.com).Themembranes
were blocked with 5% (wt/vol) skim milk (BD Biosciences) and incu-
bated with anti-b-catenin (1:2,500; Abcam), phosphorylated PKC
(pPKC; 1:1,000; Cell Signaling, Beverly, MA, http://www.cellsignal.
com)andanti-b-Actin(1:20,000;Sigma-Aldrich)at4°Covernight.Then,
themembraneswere stainedwithhorseradishperoxidase-conjugated
secondary antibody (1:5,000; GE). The antibodies were detected
with an enhanced chemiluminescence detection system (GE) and
observed with ImageQuant LAS4000 (GE). The band intensity was
determined by using ImageQuant TL (GE).
Polymerase Chain Reaction
Total RNAwas purified from samples at various time points by us-
ing the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany, http://
www.qiagen.com). More than 50 ng of total RNA were reverse-
transcribed by using SuperScript III Reverse Transcriptase and
Oligo-dT (Invitrogen). Quantitative polymerase chain reactions
(qPCRs) were carried out with SYBR Premix Ex Taq and the Ther-
mal Cycler Dice Real Time System (TaKaRa Bio Inc., Shiga, Japan,
http://www.takara-bio.co.jp). The data were assessed by using a
delta-Ct method and normalized by GAPDH expression. Reverse-
transcription PCR was carried out with Ex Taq (TaKaRa). The PCR
products were separated by electrophoresis on an agarose gel
(Sigma-Aldrich) and detected underUV illumination (AMZ system
science, Osaka, Japan, http://www.amzsystemscience.com). The
primers used for PCR are listed in Table 1.
Table 1. Primers used for PCR
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Statistical Analysis
Values are expressed as means6 SEM. All statistical analyses were
performedbyusingGraphPadPRISMsoftware (Version6;GraphPad
Software Inc., La Jolla, CA, http://www.graphpad.com). For compari-
son of three or four groups, the statistical significance of differences
was determined by one-way analysis of variance followed by Tukey’s
post hoc test. For comparisonof twogroups, unpaired t testwasused.
Probability values less than5%wereconsideredstatistically significant.
RESULTS
C59 Efficiently Induced Anterior Cortex From
Human iPSCs
We tried to generate dorsal telencephalon from human iPSCs
(836B1) based on an SFEBq method [11–13] with dual SMAD in-
hibition (SB431542 and LDN193189) [23, 24] (Fig. 1A). We chose
this method to induce frontal neurons [13], because differentia-
tion by monolayer culture tends to induce posterior cortex [10,
17]. We started differentiation in the presence of either dimethyl
sulfoxide (shown as control in the figures), DKK1, XAV, or C59, and
continued the culture until day 18.
First, we confirmed the effects of theWNT inhibitors on human
iPSCs. Analysesof the aggregatesbyWesternblot and immunostain-
ingusingab-cateninantibody revealed that all inhibitors suppressed
b-catenin stabilization and nuclear transition on day 18 (Fig. 1B and
supplemental online Fig. 2), indicating that they inhibited canonical
Wnt signaling. However, only C59 suppressed pPKC, indicating that
it also inhibited noncanonical Wnt signaling, as reported previously
[19]. Neuronal cells in the developing brain secrete several WNTs
[25]. Therefore, we examined the expression ofWNTs by the iPSC-
derived neuronal cells. Quantitative PCR analyses revealed that
C59 suppressed the expression of WNT3A and WNT8B, which are
expressed in a caudal-high gradient of the cortex [26] (Fig. 1C, 1D).
Next, we examined the expression of various differentiation
markers until day 18 (Fig. 1E). The expressions of two undifferenti-
ated markers (OCT3/4 and NANOG) were decreased as differentia-
tionprogressed. In contrast, theexpressionofanectodermalmarker
(SOX1), a telencephalon marker (SIX3), and dorsal telencephalon
markers (EMX1, PAX6, and LHX2) increased with the progression.
The expression of FEZF2, which is required for the birth and specifi-
cation of CMNs [27], also increased.Markers for endoderm (SOX17),
mesoderm (BRACHYURY), midbrain (EN1), and hindbrain and spinal
cord (HOXB4) were not detected (data not shown). These results in-
dicated that dorsal telencephalon was induced by this protocol. As
a next step, we examined the expressions of an anterior marker
(FOXG1) [28] and two posterior markers (EMX2 and COUP-TF1)
[29]. Quantitative PCR analyses revealed that the expression of
FOXG1 was increased in the presence of C59, and that of EXM2
and COUP-TF1 was suppressed by either C59 or XAV (Fig. 1F–1H).
These results suggested that C59 induced anterior cortex efficiently
compared with DKK1 or XAV.
We confirmed this finding by immunocytochemistry of the
induced cell aggregates. The aggregates were attached onto
ornithine-fibronectin-laminin-coated dishes on day 18 and
Figure 1. Cerebral cortex differentiation and expression analyses.
(A): Schematic diagram of the culture procedure for cortical neuron
differentiation. (B):Western blotting analysis on day 18. Each WNT
inhibitor inhibited Wnt/b-catenin-dependent signaling during the
SFEBqdifferentiationprocedure, but C59also inhibitedWnt/b-catenin
independent signaling. (C, D): Time course analyses of the expression
ofWNT factors show characteristics of a rostral-low and caudal-high
gradient. (E): Gene expression analyses of various differentiation
markers. The expressions of undifferentiation markers, OCT3/4 and
NANOG, were decreased, while the expressions of telencephalon
markers, SIX3, EMX1, PAX6, and LHX2, and of the specificationmarker
of corticospinal motor neurons, FEZF2, were increased. (F–H): Time
course analyses of the expressions ofmarkers for the telencephalic re-
gion. Differences were considered significant by ANOVA and Tukey’s
test. p, p, .05; pp, p, .01; ppp, p , .001; pppp, p , .0001 (n = 4).
Abbreviations: bFGF, basic fibroblast growth factor; C59, WNT-C59;
DMEM, Dulbecco’s modified Eagle’s medium; GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; KSR, Knockout Serum Replacement;
OFL, ornithine-fibronectin-laminin; pPKC, phosphorylated PKC; SFEBq,
serum-free floating culture of embryoid body-like aggregateswith quick
reaggregation; XAV, XAV939.
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incubated inneurobasal/B27mediumuntilday32.Rosette-likestruc-
tures were formed in the aggregates, and two postmitotic neuronal
makers, MAP2ab and TUJ1, were expressed outside the structures
(Fig. 2A). The aggregates expressed PAX6, SOX1 (Fig. 2B), and SOX2
(supplemental online Fig. 3), which are markers for neuroepithelium
or radial glia, indicating that early neural cells formed rosette-like
structures andmigrated out of them to becomepostmitotic neurons.
Because human ESC-derived neural cells spontaneously acquire an
intracortical dorsocaudal-ventrorostral polarity during differentia-
tion [13], we next examined the expression of a rostral marker,
SP8, and a caudal marker, COUP-TF1, in the aggregates. Immu-
nostaining revealed that C59 induced more SP8+/COUP-TF12
cells (34.3 6 1.73%) than did DKK1 (0.34 6 0.12%) or XAV
(2.83 6 0.94%) (Fig. 2C, 2D). These results suggested again that
C59 induced anterior cortex efficiently compared with DKK1 or XAV.
C59 Induces Neurons in Layer V of Anterior Cortex
The cerebral cortex forms six layers as it develops [30], and sev-
eral factors are selectively expressed in these layers. BRN2 is
expressed in the ventricular and subventricular zones and upper
layers II–IV [31]. The transcription factor TBR1 is expressed in
multiple types of layers V–VI neurons [32]. The transcription fac-
tor CTIP2 is related to subcerebral projection neurons in layer V
and is essential for generating CMNs [33]. Finally, the transcrip-
tion factor SATB2 is expressed in layers II–IV and promotes cal-
losal projection neuron identity [34].
Alongwith being amarker for posterior cortex, COUP-TF1 is a
negative regulator of CMNdifferentiation [35]. Because a specific
marker for CMN has not been identified, we regarded CTIP2+/
COUP-TF12 cells as an indicator of CMN cells. Aggregates on
day 46 showed layer formation, as identified by the different ex-
pression patterns of TBR1, CTIP2, and SATB2 (supplemental online
Fig. 4A) and of BRN2 and CTIP2 (Fig. 3A). All inhibitors induced
layers VI and V, but the number of layer IV SATB2+ cells was very
Figure 2. Characteristics of the internal structure of the induced ag-
gregates on day 32. (A): Each WNT inhibitor induced the neuronal
markers MAP2ab and TUJ1 except in the rosette-like region. (B):
Rosette-like structures expressed the neuroepithelium markers
PAX6 and SOX1. (C): Rosette-like structures also expressed the rostral
marker SP8 and the caudal marker COUP-TF1. (D): The percentage of
SP8+/COUP-TF12 cells with respect to total cells was quantified in
the sections. Differences were considered significant by ANOVA and
Tukey’s test (n=3).pppp,p, .0001.Scalebars=50mm.Abbreviations:
ANOVA, analysis of variance; C59, WNT-C59; XAV, XAV939.
Figure 3. Comparison of CTIP2-expressing cells on day 46. (A): Immu-
nocytochemistry for layer and regionmarkers on day 46 using the ven-
tricular and subventricular zone marker BRN2 (white), caudal marker
COUP-TF1 (green) and layer V marker CTIP2 (red). (B, C): Percentages
ofCTIP2 (B) andCTIP2+/COUP-TF12 (C) cellswere investigated for each
WNT inhibitor. Differences were considered significant by ANOVA
and Tukey’s test (n = 3). p, p, .05; pp, p, .01. Scale bars = 50 mm.
Abbreviations: ANOVA, analysis of variance; C59, WNT-C59; DAPI,
49,6-diamidino-2-phenylindole; XAV, XAV939.
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small (supplemental online Fig. 4B, 4C). Importantly, C59 induced
more CTIP2+ cells compared with control or other WNT inhibitors
(Fig. 3B). C59 also induced more CTIP2+/COUP-TF12 cells
(30.7% 6 9.20%) compared with DKK1 (6.15% 6 2.74%) or XAV
(4.91% 6 2.73%) (Fig. 3C). Moreover, another WNT inhibitor,
LGK-794,whichhas thesamefunctionasC59, inducedcellswith sim-
ilar characteristics as those differentiated using C59 (supplemental
online Fig. 4D–4F). Other iPSC lines (1147F1 and 1231A3) and an
ESC line (Kh-1) gave consistent results (supplemental online Fig.
5).Overall, these results suggest thatC59efficiently inducedthecells
to differentiate into CMNs compared with DKK1 or XAV.
In order to confirm the rostral to caudal identity of the human
iPSC-derived cells,we continued toculture theaggregatesuntil day
60 and performed qPCR analyses to investigate the expression of
a subset of differentially regulated genes during early human neo-
cortical development (8–12 postconceptional weeks) [36]. Genes
exhibiting a rostral-high to caudal-low gradient included CTIP2,
CNTNAP2, PCDH17, ROBO1, and Cadherin8 (CDH8). On the other
hand, genes exhibiting a caudal-high to rostral-low gradient con-
tained COUP-TF1 and EMX2. qPCR analyses revealed that neural
aggregates differentiated with C59 contained more cells with ros-
tral identity compared with DKK1 or XAV (Fig. 4).
Excitatory projection neurons transmit signals to other corti-
cal regions and express VGLUT, whereas inhibitory interneurons
regulate local circuitry and express GABA. These neurons have
distinct origins and developmental programs [37]. We investi-
gated neuronal cell types in the C59-induced neural cells on
day 46. The majority was VGLUT1+ cells (65.9% 6 2.8%; Fig.
5A), and almost all CTIP2+ cells expressed VGLUT1. Among the
other types of neurons identified, 1.20%6 0.9%were GABAergic
(Fig. 5B), and 1.18%6 0.3%were dopaminergic neurons (Fig. 5C).
Serotonergic and cholinergic neurons were not detected. Because
CMNs are in layer V and also excitatory neurons, namely glutama-
tergic [38], it is likely that the iPSC-derived neurons treated with
C59 contained CMNs or their progenitors.
C59-Induced Aggregates Extended Axonal Fibers From
the Cerebral Cortex to the Pyramidal Decussation in
Adult Mice
In order to investigate whether the induced aggregates included
CMNs or their progenitors, we transplanted one aggregate (33
105 cells in 2ml of PBS) into the cortex of NOD-SCID adultmice. Six
months after transplantation, the grafts and neurites were ana-
lyzedby immunostaining for human-specificNCAM insagittal sec-
tions (Fig. 6A). The graftswere detected in allmice (6/6 in C59 and
5/5 in XAV; Fig. 6B, 6C). Then, we counted the number of human
NCAM+ fibers from the graft to the pyramidal decussation (to
measure thewidth, we covered the transplanted side of the brain
from themidline to thewhole graft, with 7 slices at 300-mm inter-
vals per animal).We foundmore axonal fibers at the striatum (Fig.
6D, 6G), pons (Fig. 6E, 6H), and pyramidal decussation (Fig. 6F, 6I)
in the case of grafts derived from C59-induced aggregates com-
pared with those from XAV-induced ones. These fibers were
found to have extended along the tract in the contralateral spinal
cord (supplemental online Fig. 6). These results suggest that the
aggregates differentiated under C59 treatment contained more
CMNs or their progenitors.
Figure4. Expressions of regionmarkers indifferentiated cells onday
60. The differentiated cells were analyzed by qPCR for rostral-high
expression genes: CTIP2 (A), CNTNAP2 (B), PCDH17 (C), ROBO1 (D),
and CDH8 (E); and for caudal-high expression genes COUP-TF1
(F) and EMX2 (G). Differences were considered significant by ANOVA
andTukey’s test. p, p, .05; ppp,p, .001 (n = 5). Abbreviations: ANOVA,
analysis of variance; C59,WNT-C59;GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; qPCR, quantitative polymerase chain reaction; XAV,
XAV939.
Figure 5. Differentiated cells produced mainly glutamatergic projec-
tion neurons on day 46. iPSC line 836B1 on day 46 expressed glutama-
tergic neurons (A), GABAergic neurons (B), and dopaminergic neurons
(C). Arrows indicate neuronalmarker+ CTIP22 cells. Scale bar = 50mm.
Abbreviations: iPSC, induced pluripotent stem cell; TH, tyrosine hy-
droxylase; VGLUT1, vesicular glutamate transporter 1.
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DISCUSSION
The induction of CMNs from ESCs or iPSCs hold promise as cell
therapy against damaged corticospinal tracts caused by neurode-
generative diseases or insults. However, neither an efficient pro-
tocol to induce CMNs nor a specific marker for CMNs is available.
In order to improve efficient induction of anterior cortex, where
CMNs are located, we compared two small WNT inhibitors, C59
and XAV, during the neuronal differentiation of human iPSCs. In-
triguingly, C59 induced more CTIP2+/COUP-TF12 cells compared
with XAV or DKK1, a common WNT inhibitor. In addition, when
grafted into the cortex of adult mice, C59-induced cells showed
more abundant axonal fiber extensions toward the spinal cord.
These results suggest that C59 induced CMNsor their progenitors
efficiently.
As towhyC59 efficiently induced anterior cortex,we consider
the following reasons. First, the C59-induced aggregates ex-
pressed a higher level of FOXG1 than those induced by DKK1 or
XAV (Fig. 1F). FOXG1 represses the expression of WNT and
BMP [26], which are expressed in the cortical hem, an embryonic
organizer of the hippocampus [12]. Second, C59 induced more
SP8-positive cells (Fig. 2D). SP8 is required for specification of
the rostral cortical identity [39]. It is induced by Fgf signaling
and subsequentlymaintains the expression of Fgf8within the ros-
tral cortical signaling center. FGF8 signaling also promotes the
expansion of the rostral telencephalon [26]. Third, C59 tended
to repress the expression of WNT3A and WNT8B compared
with XAV (Fig. 1C, D), although the value was not statistically
significant. It has been reported that these WNTs cause a
caudomedial-high/rostrolateral-low gradient in Wnt-b catenin
activity [40].We also observed the expression of a caudalmarker,
EMX2 (Fig. 1G), which is consistent with this gradient [29]. Be-
cause C59 inhibits both canonical and noncanonical Wnt signal-
ing, whereas DKK1 and XAV inhibit only canonical signaling, we
propose that a noncanonical pathwaymay play an important role
for the induction of anterior cortex,which has been suggestedbe-
fore C59 inhibits the differentiation of neural stemcells tomature
neurons [41]. Planar cell polarity (PCP) signaling, a type of nonca-
nonical Wnt signaling, is involved in embryonic morphogenesis
and the development of the nervous systemby coordinating con-
vergent extension (CE) movements [42, 43]. CE movements are
characterized by medio-lateral and rostro-caudal movements
of cells to narrow and elongate the embryo [43]. In day 18 ag-
gregates, several genes involved in CE movements, including
Figure 6. In vivo analyses of the graft at 6 months after transplantation. (A): Sagittal section of the brain. Neurites derived from the graft ex-
tended toward the spinal cord through the corticospinal tract (dotted line). (B, C): Sixmonths after transplantation, thegraft survived in thehost.
(D–F): The neurites derived from the graft could be detected at the striatum (D), pons (E), and pyramidal decussation (F). (G, H): The number of
fiberswas counted in each region (C59, n = 6; XAV, n = 5). Differenceswere considered significant by unpaired t test. p, p, .05; pp, p, .01. Scale
bars=500mm (B, C)and200mm (D–F). Abbreviations: C59,WNT-C59;CC, corpus callosum;Cx, cortex;G, graft;OB,olfactorybulb; Pyx, pyramidal
decussation; St, striatum; XAV, XAV939.
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WNT5A, DAAM-1, GLYPICAN, and ROR2 [44], were expressed
(supplemental online Fig. 7). This finding may indicate that PCP
signaling regulates CE movements for rostro-caudal formation
of the cortex.
In addition to WNTs, the effects of secreted ligands, such as
Hedgehog and Spitz, on signal transduction is regulated by palmi-
toylation [45]. The inhibition of C59-dependent palmitoylation
may be involved in the areal patterning of the induced cells [16].
Some neurons in layer V of the cerebral cortex express CTIP2
[31] and project axons to the spinal cord and the superior collicu-
lus [27, 38]. COUP-TF1 is expressed in the posterior cortex and is
involved in neuronal differentiation and areal patterning [46, 47].
CTIP2+/COUP-TF12 cells are located in the motor/frontal region
of the cerebral cortex in embryos [35] and project axons to the
spinal cord when transplanted into mouse cerebral cortex [4].
Conversely, CTIP2+/COUP-TF1+ cells are located in theoccipital re-
gionof the cortex andproject axons to the superior colliculus [10].
Therefore, we consider the induction of CTIP2+/COUP-TF12 cells
as necessary for ESC/iPSC-based clinical application to treat mo-
tor neuron diseases or insults.
CONCLUSION
We found that C59 induced CTIP2+/COUP-TF12 cells fromhuman
iPSCs more efficiently than two other WNT inhibitors, DKK1 and
XAV. Furthermore, these CTIP2+/COUP-TF12 cells extended
axons to the pyramidal decussation. These results raise the
possibility that C59 could contribute to cell-replacement therapy
for motor neuron diseases or insults.
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